Naploy App Launches with AI Diagnostics, Targets African Health Market

Naploy Corp. 10-K Filing Summary
FieldDetail
CompanyNaploy Corp.
Form Type10-K
Filed DateOct 27, 2025
Risk Levelhigh
Pages15
Reading Time18 min
Key Dollar Amounts$45,000, $0.50, $1.00, $150, $1,000
Sentimentbearish

Sentiment: bearish

Topics: Digital Health, AI Diagnostics, Startup, Pre-Revenue, African Market, Mobile App, Healthcare Technology

TL;DR

**Naploy Corp. is a pre-revenue, high-risk bet on an AI-driven health app in Africa, with 'more than 10 active users' and no current employees beyond its officers, making it a speculative venture at best.**

AI Summary

Naploy Corp., incorporated on April 6, 2023, is a Wyoming-based company focused on launching a health news blog and mobile application, the 'Naploy App.' The company has no sufficient revenue and has incurred losses since inception. Its primary offerings include a news blog, an AI-powered Symptom Diagnostic tool, and a Clinic Search feature. The Naploy App, available on iOS and Android, was launched on July 24, 2023, and currently has over 10 active users. Revenue generation is planned through advertising services (banner ads, pop-ups) with estimated prices of $0.50-$1.00 per click or $150-$1,000 monthly, and Clinic Search fees starting at $50-$500 per search. Future revenue streams may include a subscription model ($70/month), referral fees (5%-15% of service cost), and data analytics ($200-$2,000 per report). The company has no employees, relying on its officers, Mr. Frederick Sidney Reinhard Arnold and Mr. Rafael Angel Ulloa Bonilla, and plans to expand services from Nigeria to other African countries like Benin, Chad, Cameroon, and Niger within two to three years.

Why It Matters

Naploy Corp.'s entry into the digital health market, particularly with its AI-powered Symptom Diagnostic and Clinic Search features, could significantly impact healthcare access in Nigeria and potentially other African countries. For investors, the company's lack of current revenue and reliance on future collaborations for referral fees presents a high-risk, high-reward scenario in a competitive market dominated by players like Zocdoc and WebMD. Employees (future freelance managers) and customers in underserved regions could benefit from improved access to health information and clinic recommendations, but the company's current minimal user base of 'more than 10 active users' indicates a nascent stage. The broader market will watch to see if Naploy can effectively monetize its platform and scale its operations in a region with unique healthcare challenges.

Risk Assessment

Risk Level: high — Naploy Corp. is a pre-revenue company that has incurred losses since inception, indicating significant financial instability. It currently has 'no employees' beyond its officers and 'more than 10 active users' since its July 24, 2023 launch, demonstrating minimal market penetration and operational capacity. The aggregate market value of voting and non-voting common equity held by non-affiliates is stated as '$0', further highlighting its early-stage, high-risk profile.

Analyst Insight

Investors should approach Naploy Corp. with extreme caution, recognizing it as a highly speculative venture with no current revenue or significant user base. Monitor for concrete evidence of revenue generation, substantial user growth beyond '10 active users,' and the successful hiring of freelance managers before considering any investment.

Financial Highlights

debt To Equity
N/A
revenue
$0
operating Margin
N/A
total Assets
Not disclosed
total Debt
Not disclosed
net Income
Loss since inception (specific amount not detailed)
eps
N/A
gross Margin
N/A
cash Position
Not disclosed
revenue Growth
N/A

Revenue Breakdown

SegmentRevenueGrowth
Advertising Services$0N/A
Clinic Search Fees$0N/A

Key Numbers

  • $0 — Aggregate market value of common equity held by non-affiliates (Indicates no public trading or valuation for non-affiliate shares as of October 27, 2025.)
  • 3,803,370 — Common shares issued and outstanding (As of October 27, 2025.)
  • April 6, 2023 — Incorporation date (Company established.)
  • July 24, 2023 — Naploy App launch date (Official launch on Apple Store and Play Store.)
  • 10 — Active users (Number of active users for Naploy App to date.)
  • $45,000 — Cost of mobile application and website (Total consideration paid for iOS and Android platforms.)
  • $0.50-$1.00 — Estimated advertising fee per click (Projected revenue for banner ads and pop-ups.)
  • $150-$1,000 — Estimated monthly advertising fee (Projected revenue for banner ads and pop-ups.)
  • $50-$500 — Estimated Clinic Search fee per search (Projected revenue for Clinic Search feature.)
  • 5%-15% — Estimated referral fees (Future revenue from medical institutions for patient referrals.)

Key Players & Entities

  • Naploy Corp. (company) — registrant
  • Frederick Sidney Reinhard Arnold (person) — officer and director
  • Rafael Angel Ulloa Bonilla (person) — officer and director
  • Wyoming (regulator) — state of incorporation
  • Nigeria (regulator) — primary market for services
  • Zocdoc (company) — competitor in health app market
  • Healthgrades (company) — competitor in health app market
  • WebMD (company) — competitor in health app market
  • Apple Store (company) — app distribution platform
  • Play Store (company) — app distribution platform

FAQ

What is Naploy Corp.'s primary business model?

Naploy Corp.'s primary business model revolves around its 'Naploy App,' which offers a health news blog, an AI-powered Symptom Diagnostic tool, and a Clinic Search feature. The company plans to generate revenue through advertising services, Clinic Search fees, and in the future, subscription models, referral fees, and data analytics.

When was the Naploy App launched and how many active users does it have?

The Naploy App was officially launched on the Apple Store and Play Store on July 24, 2023. As of the filing date, the company reports having 'more than 10 active users.'

What are Naploy Corp.'s current revenue streams?

As of the fiscal year ended July 31, 2025, Naploy Corp. has 'no sufficient revenue' and has incurred losses since inception. Future planned revenue streams include advertising services (banner ads, pop-ups) and fees for its Clinic Search feature.

Who are the key executives and employees at Naploy Corp.?

Naploy Corp. currently has 'no employees,' only its officers and Directors, Mr. Frederick Sidney Reinhard Arnold and Mr. Rafael Angel Ulloa Bonilla. The company plans to hire freelance managers once it secures its first client for clinic search services.

What are the main risks associated with investing in Naploy Corp.?

Key risks include Naploy Corp.'s pre-revenue status, accumulated losses since inception, minimal user base of 'more than 10 active users,' and reliance on future collaborations and market penetration in a highly competitive health app market. The company also has no employees beyond its officers.

Does Naploy Corp.'s AI Symptom Diagnostic tool provide medical advice?

No, Naploy Corp.'s AI Symptom Diagnostic tool 'does not provide medical advice.' It is intended for informational purposes only as a guide to point users towards possible conditions, and users are 'strongly encouraged to seek professional medical advice.'

What are Naploy Corp.'s expansion plans?

Naploy Corp. intends to initially offer its services in Nigeria and then expand to other African countries within two to three years, starting with neighboring Benin, Chad, Cameroon, and Niger. Potential target countries for further expansion include Kenya, South Africa, and Ethiopia.

How does Naploy Corp. plan to compete in the health app market?

Naploy Corp. plans to compete through its marketing strategy and continuous development of new features, such as improved AI technology, map view, reviews, booking services, and a personal health tracker. It aims to differentiate itself in a market with established players like Zocdoc, Healthgrades, and WebMD.

Are Naploy App's features subject to regulatory approval?

Naploy App's features, including the Symptom Diagnostic, 'do not require regulatory approval in the United States, Nigeria or elsewhere because they provide information rather than direct medical advice.' However, any future referral arrangements with medical institutions will need to comply with regulatory requirements.

What is the aggregate market value of Naploy Corp.'s common equity?

As of the last business day of the registrant's most recently completed second fiscal quarter, the aggregate market value of the voting and non-voting common equity held by non-affiliates is stated as '$0'. This indicates no public trading or valuation for non-affiliate shares.

Risk Factors

  • Nascent Stage and Lack of Revenue [high — operational]: Naploy Corp. was incorporated on April 6, 2023, and has incurred losses since inception with no sufficient revenue. The Naploy App, launched on July 24, 2023, has only 10 active users, indicating a significant lack of market traction and revenue generation capability at this early stage.
  • Intense Competition in Health Information Space [medium — market]: The company operates in the health news and mobile application sector, which is highly competitive with numerous established players offering similar services. The success of Naploy App depends on its ability to differentiate and attract users in a crowded market.
  • Reliance on Officers and Lack of Employees [medium — operational]: The company currently has no employees, relying solely on its officers, Mr. Frederick Sidney Reinhard Arnold and Mr. Rafael Angel Ulloa Bonilla. This limited human capital could pose challenges for scaling operations, development, and management as the company grows.
  • Unproven Revenue Model [high — financial]: The planned revenue streams, including advertising and clinic search fees, are speculative and have not yet generated any income. The estimated pricing for these services ($0.50-$1.00 per click for ads, $50-$500 per search for clinics) is subject to market acceptance and actual performance.
  • Limited User Adoption [high — market]: As of the filing date, the Naploy App has only 10 active users. This extremely low adoption rate suggests significant challenges in user acquisition and retention, which is critical for the viability of its advertising-based revenue model.
  • Dependence on Technology Development and AI Accuracy [medium — operational]: The core features, such as the AI-powered Symptom Diagnostic tool, require ongoing refinement and improvement. The accuracy and effectiveness of this AI are crucial for user trust and engagement, and any failures could severely damage the company's reputation.
  • Geographic Expansion Challenges [medium — market]: The plan to expand services from Nigeria to other African countries like Benin, Chad, Cameroon, and Niger within two to three years involves navigating diverse regulatory environments, market conditions, and logistical complexities, which could hinder growth.

Industry Context

Naploy Corp. operates within the rapidly evolving digital health and health information sector. The industry has seen increased demand for mobile health applications, particularly post-COVID-19, driven by convenience and safety concerns. However, this space is highly competitive, with numerous platforms vying for user attention and advertising revenue.

Regulatory Implications

As a digital health information provider, Naploy Corp. may face scrutiny regarding data privacy (e.g., HIPAA compliance if handling protected health information, though not explicitly stated) and the accuracy of its AI diagnostic tool. Ensuring compliance with evolving data protection laws and healthcare information standards will be crucial.

What Investors Should Do

  1. Monitor user acquisition and engagement metrics closely.
  2. Evaluate the development and accuracy of the AI Symptom Diagnostic tool.
  3. Assess the execution of the revenue generation strategy.
  4. Observe progress on geographic expansion plans.

Key Dates

  • 2023-04-06: Company Incorporation — Marks the official establishment of Naploy Corp. as a legal entity in Wyoming.
  • 2023-07-24: Naploy App Launch — The mobile application, a core product, was made available on iOS and Android platforms, initiating its market presence.

Glossary

Common shares issued and outstanding
The total number of shares of a company's stock that have been authorized, issued, and are held by investors, including restricted shares owned by insiders and restricted shares owned by public investors. (Indicates the total equity base of the company, though with $0 market value for non-affiliates, it highlights the speculative nature of the equity.)
Aggregate market value of common equity held by non-affiliates
The total market value of shares held by investors who are not considered company insiders or affiliates. This is often used as a measure of a company's public float value. (At $0, it signifies that the company's shares are not publicly traded or have no discernible market valuation among non-affiliates as of the reporting date.)
Symptom Diagnostic
A feature within the Naploy App that uses artificial intelligence to help users identify potential medical conditions based on their reported symptoms. (This is a key technological offering of the company, intended to drive user engagement and potentially future revenue, but its AI accuracy is critical.)

Year-Over-Year Comparison

As Naploy Corp. was incorporated on April 6, 2023, and the Naploy App launched on July 24, 2023, this 10-K filing represents the company's initial disclosure. Therefore, there are no prior year figures to compare against for revenue growth, margin changes, or evolving risks. All metrics presented are from the inception of operations.

Filing Stats: 4,511 words · 18 min read · ~15 pages · Grade level 12.2 · Accepted 2025-10-27 17:29:41

Key Financial Figures

  • $45,000 — platforms for total consideration of US $45,000. Here are some of the technologies tha
  • $0.50 — d. Prices for Services: Advertising: $0.50-$1.00 per click or monthly advertising
  • $1.00 — ices for Services: Advertising: $0.50-$1.00 per click or monthly advertising $150-$
  • $150 — -$1.00 per click or monthly advertising $150-$1,000. Clinic Search: Starting at $50
  • $1,000 — 0 per click or monthly advertising $150-$1,000. Clinic Search: Starting at $50-$500 p
  • $50 — 150-$1,000. Clinic Search: Starting at $50-$500 per search, prices will vary based
  • $500 — $1,000. Clinic Search: Starting at $50-$500 per search, prices will vary based on t
  • $70 — re: Subscription Model: Starting from $70 per month, prices will vary based on th
  • $200 — total cost of service. Data analytics: $200-$2,000 per report, depending on the lev
  • $2,000 — cost of service. Data analytics: $200-$2,000 per report, depending on the level of d

Filing Documents

Management's Discussion and Analysis of Financial Condition and Results of Operations

Management's Discussion and Analysis of Financial Condition and Results of Operations. 9 Item 7A.

Quantitative and Qualitative Disclosures About Market Risk

Quantitative and Qualitative Disclosures About Market Risk. 11 Item 8.

Financial Statements and Supplementary Data

Financial Statements and Supplementary Data. 12 Item 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure. 13 Item 9A.

Controls and Procedures

Controls and Procedures. 13 Item 9B. Other Information. 14 Item 9C. Disclosure Regarding Foreign Jurisdictions that Prevent Inspections. 14 PART III Item 10. Directors, Executive Officers and Corporate Governance. 15 Item 11.

Executive Compensation

Executive Compensation. 17 Item 12.

Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters

Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters. 18 Item 13. Certain Relationships and Related Transactions, and Director Independence. 19 Item 14. Principal Accounting Fees and Services. 19 PART IV Item 15. Exhibits and Financial Statement Schedules. 20 Item 16. Form 10–K Summary. 20

Signatures

Signatures 21 i PART I

BUSINESS

ITEM 1. BUSINESS. DESCRIPTION OF BUSINESS GENERAL Naploy Corp. (referred as the "Company", "we", "our") was incorporated in the State of Wyoming and established on April 6, 2023. The Company has no sufficient revenue and has incurred losses since inception. Our primary focus is on launching a news blog that provides the latest updates on health-related topics, including but not limited to medical breakthroughs, healthy lifestyle tips, and updates on healthcare policies. We have developed a full business plan. Currently, we have no employees, only our officers and Directors - Mr. Frederick Sidney Reinhard Arnold and Mr. Rafael Angel Ulloa Bonilla. Our executive and business office is located at 95 Lias Estate Kafe district Abuja, FCT 900108 Nigeria, and our telephone number is +13072133163. The COVID-19 pandemic has had a significant impact on the healthcare industry and has led to changes in the way healthcare services are delivered, including through mobile applications that offer online information help services for finding medical institutions. Here are some ways the pandemic has affected these types of apps: Increased demand: The pandemic has increased the demand for healthcare services, and many people have turned to mobile apps to find information about medical institutions and services. Safety concerns: Many people are hesitant to visit medical institutions in person due to safety concerns, and mobile apps that offer information about medical institutions and their safety protocols can help alleviate these concerns. Our Naploy App is your go-to source for the latest health news and updates. Naploy App offers an article library- News Blog that deals with the most common health topics. Our health blog covers diverse health related concerns such as nutrition and diet, fitness, weight control, diseases, disease management, societal trends affecting health, analysis about health, business of health and health research. The app is available for both Andr

Cybersecurity

Item 1C. Cybersecurity. The Company recognizes the importance of managing cybersecurity risks to protect its information systems and data. We do not currently engage any third-party cyber

View Full Filing

View this 10-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.